HCA HCA Healthcaredata gap · 91% coverage
Health Care · Health Care Facilities · close $458.84 (2026-10-16) · latest quarter in EDGAR: 2026-03-31
HCA Healthcare (HCA) has a ThetaGrade House Rating of 49/100 (grade D), ranking #27 of 150 in Health Care. Its strongest pillars are valuation (88) and cash flow (68); its weakest is analyst sentiment (17). Data gap: 1 factor without usable data, so 91% of the method weight is covered. TTM revenue growth is 6.7% and operating margin 12.8%.
Data as of .
Data gap
No usable data for: 4Q gross-margin change. Data gap: no usable data for this factor, so it is left out and its weight is shared among the factors that do have data (no value is imputed). 91% of the full method weight is backed by data.
Analyst sentiment
weight 7.5% · 17| Consensus score (1–5) (3.8%) | derived | 20 |
| 90-day net rating shift (3.8%) | derived | 10 |
Growth
weight 30.83% · 47| Revenue growth YoY (TTM) (12.3%) | 6.7% | 33 |
| EPS growth YoY (TTM) (12.3%) | 28.9% | 68 |
| Revenue acceleration (6.2%) | -2.4% | 35 |
Profitability
weight 18.5% · 52| Operating margin (18.5%) | 12.8% | 52 |
| 4Q gross-margin change (0.0%)data gap | — | — |
Balance sheet
weight 18.5% · 23| Net debt / EBITDA (9.9%) | 3.16× | 24 |
| Current ratio (4.9%) | 0.83 | 3 |
| Interest coverage (3.7%) | 4.36× | 45 |
Cash flow
weight 12.33% · 68| FCF margin (6.2%) | 10.2% | 42 |
| FCF yield (6.2%) | 7.6% | 93 |
Valuation
weight 12.33% · 88| P/E (inverted) (6.2%) | 15.81× | 90 |
| EV/Sales (inverted) (6.2%) | 1.88× | 86 |
Technicals (EOD)
| RSI(14) | 63.1 |
| EMA 9 / 21 | 455.15 / 443.61 |
| 200-day SMA | 444.92 |
| Volume vs 20d avg | 1.29× |
| 20-day return | 6.9% |
Exit-rule monitor
- EXITRating break: House Rating below 60
- WATCHAnalyst drift: net bullish ratings down ≥2 over ~90 days
Data source per metric (SEC XBRL tag or derivation): Revenue: Revenues · Operating income: Revenue − CostsAndExpenses · Interest expense: InterestExpense · D&A: DepreciationDepletionAndAmortization · EPS: EarningsPerShareDiluted · Market cap: SEC shares (dei EntityCommonStockSharesOutstanding (cover page)) × EOD close · P/E: EOD close ÷ SEC TTM EPS (EarningsPerShareDiluted).
Get rating changes like HCA's in the free Daily Brief
The market’s key events and signals, digested before the open.
- ✓ Pre-market Daily Brief: events, headlines, rating changes (2-min read)
- ✓ Sunday: Top 5 Weekly Picks, exit alerts, CSP put watchlist
- ✓ OPEX, FOMC, CPI and jobs-day reminders
Free. Want more? See Premium (waitlist).
FAQ
- What is HCA's House Rating?
- HCA scores 49 out of 100 (grade D) as of 2026-10-16, ranking #27 of 150 Health Care stocks we cover.
- What do analysts say about HCA?
- ThetaGrade's analyst-sentiment pillar for HCA scores 17/100 against its sector peers, which we read as negative. This is our own derived score; we do not republish individual analyst ratings, counts or targets.
- When does HCA report earnings next?
- We do not have a reliable estimate for HCA's next earnings date (irregular SEC filing history); a rough window is 2026-07-24 to 2027-01-22. Check the company's investor-relations page.
- Is HCA a buy?
- ThetaGrade does not give personal advice. The House Rating is an educational, rules-based summary of public data; see the methodology for how it is built.
Sources: SEC EDGAR filings (fetched 2026-10-18), Finnhub recommendation trends, Massive EOD prices. Scores are sector percentiles; a factor without usable data is a data gap: it is left out and the remaining weights are renormalized (nothing is imputed). Educational only. Methodology